If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Regulatory News (VER)

  • There is currently no data for VER

Director/PDMR Shareholding

29 Dec 2008 10:00

RNS Number : 7651K
Vernalis PLC
29 December 2008
 



Vernalis PLC 

29 December 2008 

 

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS 

 

 

VERNALIS PLC 

 

 

WINNERSH, U.K 29th December 2008 Vernalis plc (LSE: VER) announces that in accordance with DTR 3.1.2R and  following a resolution by the Board of Vernalis plc passed in accordance with share scheme arrangements approved by shareholders, the following options over new ordinary shares of 5p each in the Company were today granted to the new Chief Executive Officer: 

 

 

Executive   No of shares Exercise Price % of Issued Share

Director under option Capital 

Ian Garland 9,750,000 5p 2.68

 

The options are exercisable between three and ten years following grant provided that the performance conditions of the option scheme are met.

 

 

Vernalis plc 

+44 (0) 118 977 3133 

Dr Peter Fellner

Executive Chairman 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSPUGUGPUPRGUC
Date   Source Headline
5th Oct 20094:40 pmRNSSecond Price Monitoring Extn
5th Oct 20094:35 pmRNSPrice Monitoring Extension
22nd Sep 20094:35 pmRNSPrice Monitoring Extension
18th Sep 20094:40 pmRNSSecond Price Monitoring Extn
18th Sep 20094:35 pmRNSPrice Monitoring Extension
15th Sep 20097:00 amRNSRecruitment Completed in V3381 Phase II Study
9th Sep 20092:29 pmRNSHolding(s) in Company
24th Aug 20094:18 pmRNSHolding(s) in Company
24th Aug 20094:18 pmRNSHolding(s) in Company
21st Aug 20095:22 pmRNSHolding(s) in Company
20th Aug 20094:48 pmRNSAdmission of Subscription Shares to GSK
12th Aug 200911:59 amRNSHolding(s) in Company
11th Aug 20094:21 pmRNSHolding(s) in Company
11th Aug 20094:19 pmRNSHolding(s) in Company
6th Aug 20097:00 amRNSAnnouncement of Interim Results
6th Aug 20097:00 amRNSVernalis and GlaxoSmithKline enter collaboration
6th Aug 20097:00 amRNSInterest in shares in Vernalis plc
21st Jul 20097:00 amRNSNew Oncology Development Candidate Announced
16th Jul 20097:00 amRNSVernalis receives milestone payment from Novartis
8th Jul 200911:00 amRNSNotice of 2009 Half Year Results
25th Jun 20091:00 pmRNSResult of AGM
3rd Jun 20097:00 amRNSInterim Management Statement
2nd Jun 20094:54 pmRNSHolding(s) in Company
2nd Jun 20092:36 pmRNSApproval for Frovatriptan in Korea secured
1st Jun 20094:43 pmRNSDirector/PDMR Shareholding
29th May 20094:39 pmRNSDirector/PDMR Shareholding
28th May 20096:27 pmRNSAnnual Information Update
21st May 20094:09 pmRNSDirector/PDMR Shareholding-Amendment
21st May 20094:02 pmRNSHolding(s) in Company
21st May 20093:58 pmRNSAGM + Annual Report Notice
20th May 20094:11 pmRNSDirector/PDMR Shareholding
20th May 20093:14 pmRNSHolding(s) in Company
18th May 20091:00 pmRNSResult of General Meeting
18th May 20097:00 amRNSResults of Placing & Open Offer
13th May 20095:11 pmRNSDirector/PDMR Shareholding
7th May 20097:00 amRNSNew three-year Collaboration with Servier
30th Apr 20097:00 amRNSPublication of Prospectus
29th Apr 20094:00 pmRNSAnnual Financial Report
29th Apr 20097:00 amRNSPlacing and Open Offer
29th Apr 20097:00 amRNSFinal Results
27th Mar 20097:00 amRNSPipeline update
29th Dec 200810:00 amRNSDirector/PDMR Shareholding
24th Dec 200812:00 pmRNSHolding(s) in Company
22nd Dec 20084:27 pmRNSHolding(s) in Company
15th Dec 20084:35 pmRNSPrice Monitoring Extension
19th Nov 20084:30 pmRNSDirector Directorships Declaration
14th Nov 20087:00 amRNSAppointment of new CEO and new CFO
14th Nov 20087:00 amRNSInterim Management Statement
13th Nov 20084:42 pmRNSSecond Price Monitoring Extn
13th Nov 20084:37 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.